Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial.

Auteurs

Carausu M, Neven P, Ignatiadis M

  • Date de publication

    February 2025

  • Type

    Editorial Material

  • Review

    Ann Oncol

  • Researcher's name

    IGNATIADIS MICHAIL

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine Oncologique

  • PMID

    39880556

  • DOI

    10.1016/j.annonc.2025.01.004